Novavax | NVAX - 営業利益





営業利益 変化する 日付
Adma Biologics USD 62.75M 11.74M 2025-12
Agenus USD 14.4M 19.26M 2025-12
AstraZeneca USD 7.11B 4.14B 2026-03
BioCryst Pharmaceuticals USD 260.38M 230.79M 2025-12
Cassava Sciences USD -13.55M 1.69M 2025-12
Geron USD -10.79M 3.1M 2025-12
GlaxoSmithKline GBP 2.29B 856M 2026-03
MannKind USD -69.24M 28.19M 2025-12
Merck USD -1.88B 8.12B 2026-03
Minerva Neurosciences USD -21.85M 17.48M 2024-12
Moderna USD -1.39B 531M 2026-03
Novartis USD 4.06B 521M 2025-12
Novavax USD 20.94M 100.32M 2025-12
Pfizer USD 4.65B 3.99B 2025-12
Sanofi EUR 1.94B 239M 2026-03
Sarepta Therapeutics USD -410.08M 347.2M 2025-12
TG Therapeutics USD 50.49M 21.13M 2025-12